Sensus Healthcare reports Q4 EPS 9c, consensus 12c

Reports Q4 revenue $13.1M, consensus $10.53M. “Our fourth quarter performance capped an outstanding year with key metrics reflecting the growing adoption of our SRT systems. We are proud to have achieved record-high quarterly unit shipments, along with continued profitability,” said Joe Sardano, Chairman and Chief Executive Officer of Sensus Healthcare (SRTS). “Our Fair Deal Agreement program serves new customers who are seeking clinical value and financial flexibility. Our primary focus is on securing exclusive agreements with corporate accounts, and then supporting a targeted, high-impact rollout utilizing our data, resources and unmatched experience. We have had great success with this program since its launch a year ago, and expect it to begin contributing to revenues in the second half of 2025.”